Two families welcome good news
TWO families including one from Aydin, have achieved funding for their children who have the Spinal Muscular Atrophy (SMA) condition As a result of the test performed in Dubai, it was determined that 3-year-old Alparslan Sarıboğa, who has SMA Type 1 patient in Aydın, could take the Zolgensma drug used in the treatment. Zolgensma gene therapy…
Read More